The "FeMorning 10.22" covered a range of topics including the recent developments in autumn grain transportation; concerns and speculations about the possible cabin explosion phenomenon in the shipping market; fierce competition among new energy vehicle companies with the emergence of M7 orders; popularity and competitive landscape around the GLP-1 drug semaglutide and resurgence of equity investment enthusiasm among insurance companies.